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Abstract
Background: Chronic pelvic pain (CPP) in women is persistent, intermittent cyclical and non-cyclical lower
abdominal pain, lasting for more than 6 months. Traditional Chinese Medicine (TCM) is a popular treatment option
for women’s health conditions, but little is known about how treatment for CPP is delivered by TCM practitioners.
The aim of this survey was to explore practitioners understanding and treatment of women with CPP, and how
they integrate their management and care into the health care system.
Method: An online cross-sectional survey of registered TCM practitioners in Australia and New Zealand between
May and October 2018. Survey domains included treatment characteristics (e.g. frequency), evaluation of treatment
efficacy, referral networks, and sources of information that informed clinical decision making.
Results: One hundred and twenty-two registered TCM practitioners responded to this survey, 91.7% reported
regular treatment of women with CPP. Treatment decisions were most-often guided by a combination of
biomedical and TCM diagnosis (77.6%), and once per week was the most common treatment frequency (66.7%) for
acupuncture. Meditation (63.7%) and dietary changes (57.8%) were other commonly used approaches to
management.
The effectiveness of treatment was assessed using multiple approaches, most commonly pain scales, (such as the
numeric rating scale) and any change in use of analgesic medications. Limitations to TCM treatment were reported
by over three quarters (83.7%) of practitioners, most commonly due to cost (56.5%) and inconvenience (40.2%)
rather than safety or lack of efficacy. Sources informing practice were most often Integration within the wider
healthcare system was common with over two thirds (67.9%) receiving referrals from health care providers.
Conclusion: TCM practitioners seeing women with various CPP symptoms, commonly incorporate both traditional
and modern diagnostic methods to inform their treatment plan, monitor treatment progress using commonly
accepted approaches and measures and often as a part of multidisciplinary healthcare for women with CPP.
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Introduction
Chronic pelvic pain (CPP) in women is defined as inter-
mittent and continuous, cyclical and non-cyclical lower
abdominal pain, lasting for more than 6months [1, 2]. It
is characterised by diverse pain symptoms including dys-
menorrhea, dyspareunia, dyschezia and dysuria as well
as considerable fatigue and negative impacts on mental
health [3, 4]. Women with CPP are often encumbered
with a substantial, physical, psychological, emotional, so-
cial and economic burden [5–8].
CPP prevalence in women worldwide ranges between
2.1 to 81% [9, 10]. In Australia, it is estimated to affect
approximately 21.5% of reproductive aged women [10].
CPP represents 3.8% of primary care presentations, [11]
and up to 10% of outpatient referrals to gynecologists
[12]. Endometriosis and vulvodynia are two of the most
commonly diagnosed causes of CPP in women of repro-
ductive age, with estimated lifetime prevalence rates for
endometriosis of approximately 11% in Australia [13]
and 8–16% for vulvodynia, [14, 15]. Other conditions
that may cause CPP symptoms include painful bladder
syndrome, fibroids, chronic urinary tract infection, irrit-
able bowel syndrome, inflammatory bowel disease and
malignancy, as well as injuries related to childbirth,
neurological entrapment and psychological and psycho-
social factors [1]. CPP, regardless of cause, is signifi-
cantly associated with an increased risk of psychological
morbidity [16] and significantly lowered quality of life
[5, 8]. Women may be negatively impacted in several as-
pects of their lives including employment, friendships,
sexual and romantic relationships, academic study and
social activities [5, 8]. Clinical guidelines recommend
specific treatments for improving women’s functional
ability, [17] however many treatments have limited ef-
fectiveness for reducing pain symptoms, [18] which is
often a primary unmet health care need of women with
diagnosed endometriosis [19]. Women with CPP due to
endometriosis often report effective pain relief following
surgical excision of endometriosis however surgical exci-
sion is costly and recurrence rates of pain are high with
50% of women reporting recurrence at 5 years post-
surgery [18, 20]. Between 50 to 75% of women with CPP
report discontinuing pharmaceutical pain management
due to adverse side-effects and often explore other forms
of treatment including healthcare professions from out-
side of the dominant biomedicine system [6, 21, 22].
Traditional, complementary and integrative medi-
cine (TCIM) is used by 51% of women with CPP [23,
24]. Traditional Chinese Medicine (TCM) including
acupuncture [24, 25] and Chinese herbal medicine
[25] are popular TCIM treatments for which there is
preliminary, but promising evidence of effectiveness
for CPP pain reduction [26, 27]. However, despite
women’s self-directed approach to care and utilisation
of TCIM, referrals between medical doctors and TCM
practitioners in Australia and New Zealand are often
low, [28] and impeded by limited interprofessional
communication [29]. Part of this may be due to the
differences between health care frameworks including
the holistic view of the TCM theoretical paradigm
and the connected and inseparable body, mind and
emotions in contrast to the more Cartesian thinking
amongst biomedicine, which tends to view the body
as a collection of mechanistic interactions and em-
phasises mind–body duality [30]. TCM practitioners
have historically identified conflict between these two
theoretical frameworks, with TCM being “largely in-
compatible” with the mechanistic framework that un-
derpins biomedicine [31]. Therefore, it is currently
unclear what role, if any, biomedical diagnosis and
outcome evaluations play when TCM practitioners are
treating women with CPP, and how they integrate
their treatment as part of the larger, predominantly
biomedical healthcare systems in Australia and New
Zealand. Given the limited evidence on this topic, this
study aims to explore TCM practitioner knowledge
and the clinical approach to managing women with
CPP and integration of TCM clinical practice in
Australia and New Zealand.
Method
Setting
The study presents a cross-sectional survey of TCM
practitioners within Australia and New Zealand. Partici-
pants were recruited through three professional associa-
tions; the Australian Acupuncture and Chinese
Medicine Association (AACMA), the Federation of
Chinese Medicine and Acupuncture (FCMA), and Acu-
puncture New Zealand. Registered members of the asso-
ciations were emailed an invitation to participate
between June and September 2018. Interested partici-
pants were provided with a participant information
sheet, before recruitment commenced, that outlined the
anonymity of the survey and implied consent at end-
submission. Reminder invitations were sent via the asso-
ciations in June, August, and September in 2018. The
survey was conducted via web-based QualtricsXM [32]
and opened for data collection in May 2018 and closed
in October 2018.
Participants
Participants were eligible for inclusion if they were regis-
tered with one of the above associations and self-
identified as managing women’s health in their clinical
practice. Additional inclusion criteria included English
language skills and access to an internet connected de-
vice to complete the survey.
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Survey instrument
The survey was a self-administered questionnaire
uploaded into the cloud-based survey administration
platform Qualtrics XM [32]. Thirty three items were de-
signed to describe TCM practitioner’s practice charac-
teristics and their management of women with CPP
(Supplementary File 1). Practice domains included prac-
titioner’s understandings and definitions of CPP, sources
of clinical information, types of interventions used, treat-
ment patterns, interdisciplinary referrals and communi-
cation, methods used to evaluate efficacy and adverse
effects, and practitioner perceived barriers to care.
The first item sought information about the propor-
tion of women with CPP attending the practice for treat-
ment. Subsequent items sought information about the
practice characteristics including signs and symptoms of
women presenting with CPP, the types and frequency of
treatments for CPP and associated symptoms, practi-
tioner perceived effectiveness, frequency of adverse ef-
fects including negative interactions with pharmaceutical
treatments. Frequency of practitioner’s review of treat-
ment effects was reported on an eleven-point Likert
scale ranging from every week to once per year and/or
every menstrual cycle to every third menstrual cycle.
Number of treatments required to reduce CPP or associ-
ated symptoms was reported on a seven-point Likert
scale ranging between 1 and 3 treatments up to more
than 20 treatments, and with two options to report
‘treatment rarely reduced pain’ or ‘did not reduce pain’.
Further items sought information about interdisciplinary
referral networks and sources of information about CPP
and treatment decisions. Frequency of interprofessional
referrals during the previous eight weeks were reported
on a four-point Likert scale ranging from zero to seven
or more. Socio demographic characteristics and geo-
graphical location of practice were also sought. Multiple
response options were available for most items to cap-
ture all information. The questionnaire took 15–20min
to complete. The questionnaire was tested for logic and
readability by piloting with three Chinese medicine
(CM) practitioners and edited in response to their feed-
back to improve question clarity.
Ethics approval
The study was approved by the Western Sydney Human
Research ethics Committee (EC00314) H12527 on the
24th of January 2018 and the Endeavour Human Re-
search Ethics Committee (EC00358) #20180212 on the
12th of February 2018.
Data analyses
Data were exported from Qualtrics into Microsoft 365
Excel (version 16.0) for data cleaning and statistical ana-
lysis. Responses from participants that did not treat
women but completed the survey were removed. Binary
and categorical variables were generated as per the sur-
vey questions for descriptive analysis. Descriptive statis-
tics were reported using proportions and percentages.
Responses to ‘other’ were reported narratively.
Results
TCM practitioner socio-demographics
Two thousand four hundred and seventy-four registered
practitioners were invited to complete the survey. One
hundred twenty-two participants responded and re-
ported regularly consulting with women, of which 111
practitioners (91.7%) reported they regularly treated
women with CPP in their clinical practice (overall re-
sponse rate 4.9%). (Fig. 1) Twenty-one (18.9%) partici-
pants reported treating a woman with CPP at least once
every day they were in clinic. Most practitioners were
women aged over 40 years (n = 53, 47.7%), in clinical
Fig. 1 Self-reported Traditional Chinese Medicine Practitioners
treatment of women with chronic pelvic pain
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practice for over 15 years (n = 52, 16%) and practicing
4–5 days per week (n = 38, 34.2%). (Table 1).
Women’s chronic pelvic pain symptoms
Some key symptoms related to CPP, including dysmen-
orrhoea (n = 58, 52.3%) and pelvic pain related low qual-
ity of life or increased absenteeism (n = 37, 33.3%) were
regularly treated, however some common CPP symp-
toms were not often treated including dyspareunia (n =
15, 13.5%) and dyschezia (n = 12, 10.8%). (Table 2). All
TCM practitioners reported that at least one in four
women with CPP presented an abnormal menstrual pat-
tern according to TCM principles which was defined as
an imbalance between yin and yang, temperature irregu-
larities and by stagnation or insufficient life energy or
Qi. The severity of pain was mostly assessed by ques-
tions during the consultation (n = 72, 64.9%), and about
two thirds (n = 67, 60.4%) used a scale to assess the se-
verity of pain and over half (n = 62, 55.8%) asked about
the amount of pharmaceutical analgesia frequently used.
Over half (n = 62, 55.9%) assessed women presenting
with CPP using traditional Chinese medicine character-
istics of pulse and tongue.
TCM practitioners reported potential pathological
causes of CPP in women they saw in clinic as endomet-
riosis (n = 74, 66.7%), fibroids (n = 66, 62.2%), inflamma-
tory bowel disease (n = 63, 53.2%), polycystic ovary
syndrome (n = 59, 53.2%), urinary tract infections (n =
59, 53.2%) and structural disorders of the lower back
(n = 55, 49.5%). Eighteen participants (16.2%) reported
other causes including interstitial cystitis, pudendal
neuralgia, adhesions from surgery and due to adverse ef-
fects of medically assisted reproductive technologies
(ART). Women with CPP were directly referred for bio-
medical pathology tests ‘often’ by 13.5%, (n = 15), ‘some-
times’ by 10.8%, (n = 12), but ‘never’ by 38.7% (n = 43) of
TCM practitioners.
TCM approach to chronic pelvic pain case management
A combination of biomedical and TCM diagnosis most
often guided treatment decisions (n = 62, 55.8%), and
17.1% (n = 19) relied only on TCM principles. Sources
guiding treatment were most often text-books and lec-
ture notes (n = 38, 34.2%), followed by peer reviewed
academic articles (n = 31, 27.9%), updates published on-
line (n = 29, 26.1%) and discussion with clinical peers
(n = 25, 22.5%). Other guiding treatment sources in-
cluded Facebook posts, classic texts and hair tissue ana-
lyses of heavy metal concentration reported by seven
(6.3%) TCM practitioners.
Pathological mechanisms understood to contribute to
CPP in women included hyper-inflammation (n = 61,
60.4%) and muscle spasm (n = 44, 39.6%). One respond-
ent cited oestrogen dominance as the main underlying
mechanism of CPP in women. TCM patterns commonly
reported included blood stasis (n = 76, 68.5%), Qi stag-
nation (n = 65, 58.6%), cold stagnation (n = 70, 63.1%),
yang deficiency (n = 53, 47.7%) and damp phlegm (n =
57, 51.4%). Just over 7 % (n = 21, 7.2%) reported other
TCM patterns associated with CPP including disturb-
ance of the Shen, damp heat in the lower Jiao, and cold
damp liver and spleen.
Sources of information about women with CPP in-
cluded TCM texts (n = 56, 50.5%), short seminars (n =
54, 48.6%), professional association seminars (n = 54,
44.1%), on-line courses (n = 41, 36.9%) and TCM men-
tors and teachers (n = 44, 39.6%). Western medicine in-
formation sources informed CPP understanding by
36.0% (n = 40) and 41.4% (n = 46) referred to articles in
peer reviewed literature. Eight percent (n = 9) reported
referring to other sources including websites of women’s
health centres of excellence (for example Jean Hailes)
and social media forums, such as collegial Facebook
groups.
Acupuncture was the most frequently used treatment
modality (n = 81, 73.0%), provided once per week (n =
54, 48.7%) followed by moxibustion (n = 67, 60.4%), diet-
ary changes (n = 64, 57.6%), nutritional supplements
(n = 56, 50.5%), Chinese herbal medicine (granules (n =
53, 47.7%), patent herbal medicines (n = 53, 47.7%) and
raw herbs (n = 35, 31.5%)), meditation (n = 44, 39.6%),
and Chinese exercises (n = 37, 33.3%). Chinese massage
was used by 34.2% (n = 38) of practitioners. (Fig. 2).
TCM treatment effectiveness
Over 70% (n = 79, 71.2%) of TCM practitioners reported
they perceived their treatment was effective in managing
pain associated with CPP, following up to 12 treatments
(n = 81, 73.0%). Various approaches for assessing treat-
ment effectiveness were utilized as outlined in Fig. 3.
Women’s pain was assessed during case consultation
and history note taking (n = 59, 53.2%) and measured ei-
ther using patient-reported pain scales (n = 55, 49.5%)
and/or through the type and quantity of analgesic medi-
cation needed to control pain (n = 53, 47.7%). TCM
diagnostic techniques (including diagnosis of tongue and
pulse characteristics) were used by 51 (45.9%) practi-
tioners to evaluate the progress of treatment. Other
methods of evaluating efficacy included the use of visual
analogue scales and abdominal palpation. The least re-
ported assessment tool for pain was the use of validated
instruments (n = 16, 14.8%). Treatment efficacy was
reviewed every menstrual cycle month by a quarter of
respondents (n = 28, 25.2%).
Treatment limitations and adverse events
Practitioners’ perceptions of limitations and barriers to
TCM treatment of women with CPP were reported by
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Table 1 Demographic characteristics of Traditional Chinese Medicine practitioners treating women with CPP
n = 111 N %
Age
18–24 years 0 0
18–30 years 5 4.5
30–40 years 20 18.0
Over 40 years 53 47.7




Prefer to not disclose 1 0.9
No answer (Missing data) 33 29.7
Practice characteristics
Employed with salary 6 5.4
Self-employed in own business 72 64.9
Full-time student 6 5.4
Informal practice (friends & family) 1 0.9
Not practicing at present 1 0.9
Other (teaching) 1 0.9
No answer (Missing data) 33 29.7
Number of days per week in clinical practice
1 day per week 6 5.4
2–3 days per week 25 22.5
4–5 days per week 38 34.2
6–7 days per week 9 8.1
No answer (Missing data) 33 29.7
Years in practice
Less than 1 year 2 1.8
1–3 years 6 5.4
3–6 years 8 7.2
6–10 years 15 13.5
10–15 years 15 16.0
more than 15 years 52 46.8





No answer (Missing data) 44 39.6
Country of undergraduate qualification
Australia 60 54.1
New Zealand 5 4.5
China 6 5.4
UK or US 7 6.3
No answer (Missing data) 33 29.7
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93 (83.7%) practitioners, most often due to financial ex-
pense (n = 52, 46.8%) and the inconvenience (n = 37,
33.3%) of frequent clinical treatments (n = 37, 33.3%).
Limited evidence of effectiveness for treatment was cited
as a barrier to treatment by 27 (24.3%) and adverse ef-
fects of treatment we reported by 12.6%, (n = 14) of
practitioners. The most reported adverse effects were
worsening intensity of pain, or pain occurring at add-
itional menstrual cycle phases, such as mid-cycle. Ad-
verse effects were most often associated with
acupuncture treatment (n = 11, 9.9%), including a re-
ported serious adverse event of bowel obstruction.
Interdisciplinary referrals and communications
Integration within the wider healthcare system was com-
mon with half (n = 55, 49.5%) reporting referrals from
other health practitioners including 12.4% (n = 14) re-
ceiving seven or more referrals in the previous two
weeks. General Practitioners (GPs) were the most com-
monly referring practitioners (n = 29,29.1%), followed by
osteopaths (n = 25, 22.5%), physiotherapists (n = 22,
19.8%), massage therapists (n = 21, 18.9%) and naturo-
paths (m = 18, 16.2%). Western biomedical practitioner’s
referrers to TCM included gynaecologists (n = 8, 6.3%),
pelvic physiotherapists (n = 7, 6.3%), exercise physiolo-
gists (n = 6, 5.4%) and pharmacists (n = 4, 3.6%). Back-
ground letters of introduction were sometimes provided
by referring of practitioners (n = 24, 21.6%), however
18.0% (n = 20) of TCM practitioners reported never re-
ceiving background letters for referred women with
CPP.. Only one practitioner reported regular receipt of
written introductions from referring practitioners.
Over half (n = 59, 53.2%) of TCM practitioners re-
ported regularly referring women with CPP to other
practitioners, including five (4.5%) referring over seven
times in the previous two weeks. Referrals were most
Table 2 Symptoms of women with CPP presenting to Traditional Chinese Medicine practitioners
Number of women with CPP presenting with this














All 0 (0) 0 (0) 0 (0) 0 (0) 2 (1.8)
At least 3 of 4 0 (0) 0 (0) 11 (12.2) 5 (4.5) 17 (15.3)
Over half 2 (1.8) 2 (1.8) 22 (24.4) 12 (10.8) 29 (26.1)
1–2 of 4 10 (9.0) 13 (11.7) 25 (27.8) 20 (18.0) 23 (20.7)
Less than 1 in 4 79 (71.2) 77 (69.4) 32 (35.6) 55 (49.5) 21 (18.9)
No response (missing data) 20 (18.0) 19 (17.1) 21 (18.9) 19 (17.1) 19 (17.1)
*In TCM the menstrual cycle is determined by a range of clinical features including the regularity of menstrual periods, menstrual period duration, characteristics
of the pulse and tongue and by the colour and consistency of menstrual blood to assess the yin and yang balance, temperature regulation and life-force (Qi)
of individuals
Fig. 2 Frequency of treatment provided by TCM practitioners to women with CPP (n = 111)
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often to western biomedical providers including GPs
(n = 33, 29.7%), gynaecologists (n = 20, 18.0%), pelvic
(n = 11, 9.9%) and general physiotherapists (n = 10,
9.0%) and exercise physiologists (n = 8, 7.2%). Referrals
to other TCIM practitioners were also common and in-
cluded osteopaths (n = 25, 22.5%), chiropractors (n = 19,
17.1%), massage therapists (n = 16, 14.4%) and naturo-
paths (n = 11, 9.9%). Letters of introduction were re-
ported as ‘always’ being provided by eleven (9.9%) TCM
practitioners, ‘sometimes’ by 20 (18.0%) and ‘never’ by
24 (21.6%) TCM practitioners. Nearly one in five TCM
practitioners (n = 20, 18%) reported never referring
women with CPP to other health or medical
practitioners.
Discussion
This study provides insight into how TCM practi-
tioners manage women presenting to them with CPP.
Pelvic pain symptoms such as dyspareunia was an un-
common presenting symptom despite affecting almost
three quarters of women with CPP [33] and may re-
flect the normalization of pelvic pain associated with
the menstrual cycle [34] and/or TCM practitioners
overlooking signs and symptoms associated with CPP.
Just under two thirds of Australian women with CPP
do not exclusively pursue or continue with medical
care [10, 35]. They are motivated to use self-help
measures and (self-perceived) low risk, natural inter-
ventions including TCIM practitioners, whose prac-
tices are often based on holistic philosophies, and
may provide whole person alternatives and adjuncts
to Western biomedical management, which is an
expressed need of women with CPP [36]. The major-
ity of TCM practitioners provided treatment informed
by both biomedical and TCM sources. Most practi-
tioners in this study perceived their treatments were
effective however few reported evaluating the efficacy
of treatments using validated methods.
TCM practitioners in our sample did not commonly
use peer reviewed academic articles as part of their clin-
ical practice, similar to previous research showing that
clinical trial results do not always change practice for
acupuncture practitioners [37, 38]. This may be due to
practitioners’ perceptions that randomised clinical trials
are not relevant to acupuncture practice, [39, 40]. How-
ever, negative attitudes towards acupuncture cited in
clinical practice guidelines for CPP, may also distort
TCM practitioners’ attitudes towards evidence-based
practice. Derogatory reference to female users of acu-
puncture as ‘desperate’, [1] not only diminishes women
with CPP using TCM, it describes a negative prejudice
as the quality of evidence was similarly low for some
medical treatments as it was for acupuncture, and yet
medical users were not described as desperate. A nega-
tive prejudice in clinical guidelines may devalue TCM
practitioners perceptions of evidence based clinical prac-
tice. There are a number of other factors that can im-
pede translation of clinical trial results into community
health practices, including financial and time barriers
[41], similar to that reported by practitioners in this sur-
vey. This is a concern as the total number of treatments
given might be an important factor in achievement of
therapeutic outcomes [42–44], as practitioners may be
prevented from delivering optimal ‘doses’ of acupuncture
treatment [45].
Efficacy and safety has been previously demonstrated
for acupuncture in the reducing pain associated with
endometriosis [46, 47] and improving quality of life, [48,
49] with these pain improvements being clinically rele-
vant as they exceed the minimally important difference
for treatment of pain in women with endometriosis (at
least 10 mm on a 100mm visual analogue scale, or a
Fig. 3 Assessments used to measure treatment effectiveness (n = 111)
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20% in absolute pain reduction) [50–52]. Whilst over
two thirds of practitioners were using scales to assess
the severity of women pain on presentation, none re-
ported knowledge of how much reduction constitutes a
minimal important clinical effect. The absence of a vali-
dated measure of treatment efficacy may reflect TCM
lower value of research based knowledge and informa-
tion over traditional techniques, [53] which is not
unique to TCM but is critical in the integration of health
services and interprofessional communication of referral
networks.
Many practitioners reported non-integration through
referral pathways into health care settings. Barriers to in-
terprofessional referrals have been cited as being due to
biomedical dominance and a lack of clarity about each
other’s roles [54–56]. Cross-professional education and
training about practices, mutual understanding of re-
sponsibilities and limitations, and processes including
formal correspondence may assist overcoming these bar-
riers, which is important because failures in interprofes-
sional communication are a leading cause of patient
harm [29, 54, 56]. As TCM represents 11% of primary
care capability in rural areas of Australia [57] and acu-
puncturists up to 8.8% of services for women with other
reproductive needs, [58] improved integration and
shared care could improve safety as well as continuity of
care and the healthcare experiences of women with CPP.
TCM as part of multidisciplinary clinical care for women
with CPP due to endometriosis, has been shown to im-
prove women’s self-efficacy by cultivating confidence
and resilience, relieving social isolation and improving
quality of life [59].
Limitations
Limitations of this research included low response and
completion rates which reduce the validity and
generalizability of the findings. Reliance on professional
associations distribution of the survey limited the oppor-
tunity for reminder emails and there were no financial
incentives for participants. Women’s health is not a rec-
ognized specialization for TCM practitioners in Australia
or New Zealand, in contrast to other therapies such as
physiotherapy, and therefore there is no way of targeting
this particular cohort or ascertaining an accurate re-
sponse rate given the number of eligible practitioners is
unknown. Surveys of health practitioners have notori-
ously low response rates [60] and the response rate, and
total number of responses in this survey are in line with
previous data collected in the Australian and New Zea-
land setting [25]. Given these factors the findings are
generalizable to the specific sub-group/sub-specialization
of TCM practitioners who regularly treat women with
CPP. The survey instrument was cross-sectional and de-
signed to explore the subjective, self-reported opinions
of TCM practitioners in their clinical approach to
women presenting with CPP, and cannot be used to de-
termine trends or changes in practice over time. Add-
itionally, participant recall bias may have limited the
accuracy of findings in this survey, however the limited
recall period used (previous eight weeks to three months
depending on the question) should have minimized the
impact of this.
Future research
While there are limitations to this study, future research
within this topic is warranted. Further research into the
perceived effectiveness of TCM treatment from the per-
spective of women with CPP requires exploration to
identify areas relating to women’s self-motivated reasons
for TCM use, cost effectiveness, and the experience of
care these women encounter. Additionally, investigations
into how TCM including acupuncture can fit within the
current model of care for women with CPP requires ex-
ploration to identify barriers and benefits to interdiscip-
linary practices including TCM and biomedicine.
Conclusion
Traditional Chinese Medicine practitioners provide
treatments within a biomedical framework, informed by
traditional practices and perspectives, and form an im-
portant part of a multidisciplinary healthcare team when
treating women with CPP. The usage of research to
guide clinical treatments was uncommon and may repre-
sent barriers in translating clinical trials into clinical
practice. Continuity of care and safety could be im-
proved by further integration of TCM into mainstream
healthcare services which may be facilitated through im-
proved interprofessional communication.
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